Progress in the use of microarray technology to study the neurobiology of disease

K. Mirnics, Jonathan Pevsner

Research output: Contribution to journalArticle

132 Citations (Scopus)

Abstract

The diverse functions of the brain are mediated by neurons and glia whose phenotype is defined by a dynamically maintained set of gene transcripts, or 'transcriptome'. Large-scale analysis of gene expression in postmortem brain using microarray technology has the potential to elucidate molecular changes that occur in disease states. There are unique challenges associated with studies of postmortem brain, including limited sample sizes and variable clinical phenotypes that are typical of complex disorders. Nevertheless, recent microarray-based studies have implicated both individual dysregulated genes and abnormal patterns of gene expression in brain disorders.

Original languageEnglish
Pages (from-to)434-439
Number of pages6
JournalNature Neuroscience
Volume7
Issue number5
DOIs
Publication statusPublished - May 2004

Fingerprint

Neurobiology
Technology
Brain
Phenotype
Gene Expression
Brain Diseases
Transcriptome
Neuroglia
Sample Size
Genes
Neurons

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Progress in the use of microarray technology to study the neurobiology of disease. / Mirnics, K.; Pevsner, Jonathan.

In: Nature Neuroscience, Vol. 7, No. 5, 05.2004, p. 434-439.

Research output: Contribution to journalArticle

@article{e651f62181ff4ab68b22f525de07e874,
title = "Progress in the use of microarray technology to study the neurobiology of disease",
abstract = "The diverse functions of the brain are mediated by neurons and glia whose phenotype is defined by a dynamically maintained set of gene transcripts, or 'transcriptome'. Large-scale analysis of gene expression in postmortem brain using microarray technology has the potential to elucidate molecular changes that occur in disease states. There are unique challenges associated with studies of postmortem brain, including limited sample sizes and variable clinical phenotypes that are typical of complex disorders. Nevertheless, recent microarray-based studies have implicated both individual dysregulated genes and abnormal patterns of gene expression in brain disorders.",
author = "K. Mirnics and Jonathan Pevsner",
year = "2004",
month = "5",
doi = "10.1038/nn1230",
language = "English",
volume = "7",
pages = "434--439",
journal = "Nature Neuroscience",
issn = "1097-6256",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Progress in the use of microarray technology to study the neurobiology of disease

AU - Mirnics, K.

AU - Pevsner, Jonathan

PY - 2004/5

Y1 - 2004/5

N2 - The diverse functions of the brain are mediated by neurons and glia whose phenotype is defined by a dynamically maintained set of gene transcripts, or 'transcriptome'. Large-scale analysis of gene expression in postmortem brain using microarray technology has the potential to elucidate molecular changes that occur in disease states. There are unique challenges associated with studies of postmortem brain, including limited sample sizes and variable clinical phenotypes that are typical of complex disorders. Nevertheless, recent microarray-based studies have implicated both individual dysregulated genes and abnormal patterns of gene expression in brain disorders.

AB - The diverse functions of the brain are mediated by neurons and glia whose phenotype is defined by a dynamically maintained set of gene transcripts, or 'transcriptome'. Large-scale analysis of gene expression in postmortem brain using microarray technology has the potential to elucidate molecular changes that occur in disease states. There are unique challenges associated with studies of postmortem brain, including limited sample sizes and variable clinical phenotypes that are typical of complex disorders. Nevertheless, recent microarray-based studies have implicated both individual dysregulated genes and abnormal patterns of gene expression in brain disorders.

UR - http://www.scopus.com/inward/record.url?scp=2142757232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2142757232&partnerID=8YFLogxK

U2 - 10.1038/nn1230

DO - 10.1038/nn1230

M3 - Article

C2 - 15114354

AN - SCOPUS:2142757232

VL - 7

SP - 434

EP - 439

JO - Nature Neuroscience

JF - Nature Neuroscience

SN - 1097-6256

IS - 5

ER -